Clinical Trials Logo

Respiratory Tract Infections clinical trials

View clinical trials related to Respiratory Tract Infections.

Filter by:

NCT ID: NCT00585481 Completed - Clinical trials for Respiratory Tract Infection

Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian Children

Start date: January 2008
Phase: N/A
Study type: Observational

The primary objective of this study is to determine the incidence of severe RSV LRTI requiring hospitalization among infants born < 35 weeks gestational age for one year of follow-up.

NCT ID: NCT00571701 Completed - Clinical trials for Recurrent Respiratory Papillomatosis

Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis

Start date: February 2008
Phase: Phase 2
Study type: Interventional

This is a randomized double blind controlled study to determine if celebrex (celecoxib), a selective COX-2 inhibitor, can decrease the rate of recurrence in adult and pediatric patients with recurrent respiratory papillomatosis. All patients will be evaluated for disease severity at enrollment and at 3 month intervals for 30 months. After randomization, patients in the early treatment arm will begin celecoxib 6 months after enrollment. The delayed treatment arm will begin celecoxib 18 months after enrollment. All patients will receive celecoxib for 1 year. During the time that patients do no receive celecoxib, they will receive a placebo capsule with the same appearance. Follow-up visits will occur at three month intervals for the duration of the study.

NCT ID: NCT00550914 Completed - Clinical trials for Recurrent Respiratory Papillomatosis

Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRP

Start date: January 2007
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether the 585-nm pulse dye laser can decrease the time interval between surgeries and improve voice outcomes in children with severe RRP.

NCT ID: NCT00536133 Completed - Clinical trials for Acute Respiratory Infections

Role of Zinc in Recurrent Acute Lower Respiratory Infections

Start date: April 2006
Phase: Phase 3
Study type: Interventional

Acute respiratory infections (ARIs) are the most frequent illnesses globally. Despite advances in the recognition and management ARIs, these account for over 20% of all child deaths globally.Trace mineral deficiencies have long been implicated in causation and consequences of many diseases. The importance of adequate zinc intake in human health is well documented and zinc deficiency is a large public health problem, especially among children in developing countries.Various studies suggest that zinc-deficient populations are at increased risk of developing diarrhoeal diseases, respiratory tract infections and growth retardation.Among the individual interventions zinc supplementation with universal coverage ranks 5th in preventing under five mortality in India, preceded only in order by breast feeding; complementary feeding; clean delivery; Hib vaccination; and clean water, sanitation and hygiene.Numerous studies have examined the association between child mortality and zinc deficiency. A number of randomized controlled trials evaluating effect of zinc supplementation have found the intervention to be beneficial in reducing ARI and diarrhoeal mortality and morbidity but few studies have found beneficial effect in diarrhea and no or even contrasting effects on morbidity pattern of acute respiratory infections. Whereas role of zinc in diarrhea is now a well established and specific guidelines and recommendations have been given for zinc supplementation in diarrhea, role of zinc in acute respiratory infections is controversial. The contrasting effect of zinc on diarrhoea and acute lower respiratory infection as reported in several studies is a public health concern, because zinc supplementation is carried out in many nutrition rehabilitation units. Further in many of randomized control trials supplement syrups also contained other vitamins, including vitamin A, known to have effect on respiratory morbidity. Most of the trials evaluating effect of zinc on respiratory morbidity and mortality are community based and children with well known causes of recurrent acute lower respiratory infections have not been excluded from the study pool. Hence the current study was planned to bridge this gap of information and attempts to detect the role of zinc using "zinc only preparations" in reducing respiratory morbidity in children aged 6 to 59 months with recurrent acute lower respiratory infections.

NCT ID: NCT00533182 Completed - Clinical trials for Respiratory Infections

Influenza in People With Normal and Weakened Immune Systems

Start date: January 3, 2008
Phase:
Study type: Observational

This study will evaluate how the immune system responds to influenza infection and compare how the infection differs in patients with a weakened immune system versus those with a healthy immune system. Patients at the NIH Clinical Center who are older than 2 years of age and who are diagnosed with influenza A or B may be eligible for this study. Patients with healthy immune systems and weakened immune systems are included. Participants answer questions about how they are feeling and have a physical examination to evaluate their symptoms. Blood and nasal fluid are collected on the first day and then every other day for a total of 8 days. Nasal fluid is collected by either inserting a small tube in the nose and washing the nose with salt water and collecting the fluid obtained, or by rubbing the inside of the nose with a swab. Physical examinations are repeated on the days that blood and nasal fluid are collected.

NCT ID: NCT00517660 Completed - Clinical trials for Respiratory Tract Infections

Source Profiling of Biohazardous Aerosols in Hospitals

Start date: March 2006
Phase: N/A
Study type: Observational

To characterise the physical parameters (number concentration, size distribution and their trajectories) of aerosols (droplets) generated in high risk procedures.

NCT ID: NCT00514670 Completed - Clinical trials for Gastrointestinal Diseases

A Randomized Controlled Trial of a School Disinfection and Hand Hygiene Program

Start date: March 2006
Phase: N/A
Study type: Interventional

The objective of the trial is to assess the impact of a disinfection and hand hygiene program on absenteeism in elementary school classrooms. Students in intervention classrooms will use alcohol-based hand sanitizers at school, and their classrooms will be disinfected using quaternary ammonium wipes. We hypothesize that the use of disinfectants and hand hygiene products in elementary school classrooms will reduce absenteeism.

NCT ID: NCT00500578 Completed - Clinical trials for Hematological Malignancies

Intermittent Use of Aerosolized Ribavirin for Treatment of RSV

Start date: February 2003
Phase: Phase 4
Study type: Interventional

Primary Objectives: 1. To determine whether aerosolized ribavirin is effective when given at an intermittent dose over 3 hours every 8 hours for therapy of RSV upper respiratory tract infection (URI) and whether it can prevent progression to pneumonia. 2. To determine the effect of this regimen on persistence of viral shedding.

NCT ID: NCT00481507 Completed - Clinical trials for Respiratory Tract Infections

Measuring the Influence of Kefir on Children's Stools on Antibiotics (MILK)

MILK
Start date: July 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effectiveness of commercially available kefir on preventing antibiotic-associated diarrhea compared to placebo in children ages 1-5.

NCT ID: NCT00448981 Completed - Clinical trials for Respiratory Tract Infections

Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial

STUFFY
Start date: November 2006
Phase: N/A
Study type: Interventional

Colds and flu cause much loss of work and school. The purpose of this study is to try to reduce the transmission of colds and flu among household members with one of three interventions: some educational material, educational material and use of alcohol hand sanitizers, and educational material and use of alcohol hand sanitizers as well as face masks when somebody has symptoms of the flu. We will recruit 450 households in Northern Manhattan and each household will be randomly assigned to one of these three groups. We will then follow these households for 15 months to see how often they get cold and flu symptoms. We will also look at antibiotic use practices for symptoms of colds and influenza Íž household member knowledge of prevention and treatment strategies for pandemic influenza and viral URIsÍž and rates of influenza vaccination among household members. When someone in the study has serious flu symptoms such as a high fever and cough or sore throat, we will also obtain a nasal culture (by swabbing the nose) to see if there is flu virus present.